Skip to main content
Journal cover image

Using pharmacogenetics to improve drug safety and efficacy.

Publication ,  Journal Article
Haga, SB; Burke, W
Published in: JAMA
June 16, 2004

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

June 16, 2004

Volume

291

Issue

23

Start / End Page

2869 / 2871

Location

United States

Related Subject Headings

  • Thioguanine
  • Pharmacogenetics
  • Pharmaceutical Preparations
  • Methyltransferases
  • Mercaptopurine
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hydroxymethylglutaryl CoA Reductases
  • Humans
  • General & Internal Medicine
  • Drug-Related Side Effects and Adverse Reactions
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Haga, S. B., & Burke, W. (2004). Using pharmacogenetics to improve drug safety and efficacy. JAMA, 291(23), 2869–2871. https://doi.org/10.1001/jama.291.23.2869
Haga, Susanne B., and Wylie Burke. “Using pharmacogenetics to improve drug safety and efficacy.JAMA 291, no. 23 (June 16, 2004): 2869–71. https://doi.org/10.1001/jama.291.23.2869.
Haga SB, Burke W. Using pharmacogenetics to improve drug safety and efficacy. JAMA. 2004 Jun 16;291(23):2869–71.
Haga, Susanne B., and Wylie Burke. “Using pharmacogenetics to improve drug safety and efficacy.JAMA, vol. 291, no. 23, June 2004, pp. 2869–71. Pubmed, doi:10.1001/jama.291.23.2869.
Haga SB, Burke W. Using pharmacogenetics to improve drug safety and efficacy. JAMA. 2004 Jun 16;291(23):2869–2871.
Journal cover image

Published In

JAMA

DOI

EISSN

1538-3598

Publication Date

June 16, 2004

Volume

291

Issue

23

Start / End Page

2869 / 2871

Location

United States

Related Subject Headings

  • Thioguanine
  • Pharmacogenetics
  • Pharmaceutical Preparations
  • Methyltransferases
  • Mercaptopurine
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hydroxymethylglutaryl CoA Reductases
  • Humans
  • General & Internal Medicine
  • Drug-Related Side Effects and Adverse Reactions